Cognition Therapeutics Inc’s recent filing unveils that its CEO & President Ricciardi Lisa acquired Company’s shares for reported $30001.0 on Jan 31 ’25. In the deal valued at $0.77 per share,38,851 shares were bought. As a result of this transaction, Ricciardi Lisa now holds 38,851 shares worth roughly $11655.3.
B. Riley Securities upgraded its Cognition Therapeutics Inc [CGTX] rating to a Buy from a a Neutral in a research note published on December 19, 2024; the price target was increased to $1.50 from $1. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who decreased its forecast for the stock in late July from “an Overweight” to “a Neutral”. Oppenheimer began covering CGTX with “an Outperform” recommendation on November 03, 2021. B. Riley Securities started covering the stock on November 03, 2021. It rated CGTX as “a Buy”.
Price Performance Review of CGTX
On Friday, Cognition Therapeutics Inc [NASDAQ:CGTX] saw its stock fall -3.15% to $0.30. Over the last five days, the stock has gained 1.02%. Cognition Therapeutics Inc shares have fallen nearly -57.46% since the year began. Nevertheless, the stocks have fallen -85.59% over the past one year. While a 52-week high of $2.54 was reached on 01/06/25, a 52-week low of $0.22 was recorded on 05/28/25.
Levels Of Support And Resistance For CGTX Stock
The 24-hour chart illustrates a support level at 0.2902, which if violated will result in even more drops to 0.2821. On the upside, there is a resistance level at 0.3066. A further resistance level may holdings at 0.3149.
How much short interest is there in Cognition Therapeutics Inc?
A steep rise in short interest was recorded in Cognition Therapeutics Inc stocks on 2025-05-30, dropping by -0.16 million shares to a total of 0.76 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 0.91 million shares. There was a decline of -20.45%, which implies that there is a negative sentiment for the stock.
